Clivatuzumab

Clivatuzumab is a humanized anti-myxinomab, which can target the MUC1 epitope highly expressed on the surface of most pancreatic cancer cells, and has a good therapeutic effect on a variety of tumor cells.

Product Specifications

CAS Number

1622075-09-5

Stability

≥ 2 years

Purity

>98% (HPLC)

Molecular Formula

——

Notes

Research use only, not for human use.

Receptor

Others

Available Sizes

More Discoveries

Explore Other Products

Browse additional items from our catalog

RDR-NPTX1-Hu-01 96 Tests

Human Neuronal Pentraxin I (NPTX1) ELISA Kit

View Details

RDR-NPTX1-Hu-02 48 Tests

Human Neuronal Pentraxin I (NPTX1) ELISA Kit

View Details

sc-428511-LAC 200 µL

OTUD3 Lentiviral Activation Particles (m)

View Details

sc-306269 500 mg

2-[4- (tert-Butyl) phenoxy]benzenecarbaldehyde

View Details

orb3024715-01 50 mg

Pyrazomycin II

View Details

orb3024715-02 10 mg

Pyrazomycin II

View Details